Mark Hillman / Mark A. Hillman
@Hillman Capital Management, Inc.
Latest period2024 - Q3ReportedManaged Assets$291.577MTotal holdings52
Assets growth rate2.95%Assets growth rate (2-Q avg)-3.01%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Hillman Capital Management, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 52 positions.
Assets under management
The assets under management (AUM) of Hillman Capital Management, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 291.577M in assets, with a quarterly growth rate of 2.95% and a 2-quarter average growth rate of -3.01%. The portfolio is managed by Mark Hillman, Mark A. Hillman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
IFFInternational Flavors&fragra
| 3.62% | $10.527M 100,326 shares@ $104.93 avg price | Decreased -0.25% |
MSFTMicrosoft Corp
| 3.5% | $10.184M 23,668 shares@ $430.3 avg price | Decreased -0.02% |
SPGSimon Ppty Group Inc New
| 3.28% | $9.553M 56,521 shares@ $169.02 avg price | Decreased -8.23% |
WBDWarner Bros Discovery Inc
| 3.21% | $9.354M 1.134M shares@ $8.25 avg price | Decreased -2.16% |
BMYBristol-myers Squibb Co
| 2.85% | $8.301M 160,445 shares@ $51.74 avg price | Decreased -0.05% |
CVSCvs Health Corp
| 2.63% | $7.642M 121,527 shares@ $62.89 avg price | Decreased -2.25% |
USBUs Bancorp Del
| 2.56% | $7.444M 162,778 shares@ $45.74 avg price | Decreased -0.04% |
BIIBBiogen Inc
| 2.35% | $6.833M 35,253 shares@ $193.85 avg price | Decreased -1.94% |
PFEPfizer Inc
| 2.3% | $6.687M 231,059 shares@ $28.94 avg price | Decreased -0.03% |
JWNNordstrom Inc
| 2.24% | $6.506M 289,275 shares@ $22.5 avg price | Decreased 0% |